BR9809111B1 - intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos. - Google Patents

intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos.

Info

Publication number
BR9809111B1
BR9809111B1 BRPI9809111-5A BR9809111A BR9809111B1 BR 9809111 B1 BR9809111 B1 BR 9809111B1 BR 9809111 A BR9809111 A BR 9809111A BR 9809111 B1 BR9809111 B1 BR 9809111B1
Authority
BR
Brazil
Prior art keywords
ethylamino
thienyl
chlorophenyl
preparing same
intermediates
Prior art date
Application number
BRPI9809111-5A
Other languages
English (en)
Other versions
BR9809111A (pt
Inventor
Maria Bakonyi
Marianna Csatarine Nagy
Leventene Molnar
Zoltan Makovi
Piroska Jobb
Tiborne Bai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9809111A publication Critical patent/BR9809111A/pt
Publication of BR9809111B1 publication Critical patent/BR9809111B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Press Drives And Press Lines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
BRPI9809111-5A 1997-05-13 1998-05-11 intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos. BR9809111B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700884A HU225503B1 (en) 1997-05-13 1997-05-13 Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
PCT/HU1998/000047 WO1998051681A1 (en) 1997-05-13 1998-05-11 New intermediates and process for the preparation thereof

Publications (2)

Publication Number Publication Date
BR9809111A BR9809111A (pt) 2000-08-01
BR9809111B1 true BR9809111B1 (pt) 2009-05-05

Family

ID=89995117

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9809111-5A BR9809111B1 (pt) 1997-05-13 1998-05-11 intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos.

Country Status (13)

Country Link
US (1) US6258961B1 (pt)
EP (1) EP0981524B1 (pt)
JP (1) JP4282770B2 (pt)
AT (1) ATE238294T1 (pt)
AU (1) AU7444798A (pt)
BR (1) BR9809111B1 (pt)
CA (1) CA2289545C (pt)
DE (1) DE69813792T2 (pt)
ES (1) ES2195335T3 (pt)
HU (1) HU225503B1 (pt)
NO (1) NO324039B1 (pt)
PT (1) PT981524E (pt)
WO (1) WO1998051681A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226421B1 (en) 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) * 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
WO2004081016A1 (en) 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
US6858734B2 (en) * 2003-04-23 2005-02-22 Rhodia Pharma Solutions Inc. Preparation of (S)-Clopidogrel and related compounds
WO2004108665A2 (en) * 2003-04-24 2004-12-16 Sun Pharmaceutical Industries Limited A process for preparation of clopidogrel
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
CA2676121A1 (en) 2003-11-03 2005-07-14 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
PL1589019T3 (pl) * 2004-04-20 2008-12-31 Ratiopharm Gmbh Stereoselektywny sposób wytwarzania klopidogrelu
WO2006034451A2 (en) * 2004-09-21 2006-03-30 Teva Pharmaceutical Industries Ltd. Crystalline clopidogrel hydrobromide and processes for preparation thereof
MX2007010267A (es) * 2005-02-24 2007-09-11 Teva Pharma Base de clopidogrel adecuada para formulacion farmaceutica y preparacion de ella.
CA2650471A1 (en) * 2006-04-27 2007-11-08 Ind-Swift Laboratories Limited Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
CA2655844A1 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
EP2346879A1 (en) * 2008-10-24 2011-07-27 Sandoz AG A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN103483356B (zh) * 2013-09-30 2016-01-13 浙江美诺华药物化学有限公司 一种（s）-氯吡格雷的硫酸盐或盐酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
WO1998051681A1 (en) 1998-11-19
JP2001525818A (ja) 2001-12-11
HUP9700884A3 (en) 2000-06-28
BR9809111A (pt) 2000-08-01
NO324039B1 (no) 2007-07-30
AU7444798A (en) 1998-12-08
NO995532L (no) 1999-12-13
HU225503B1 (en) 2007-01-29
DE69813792T2 (de) 2004-01-29
NO995532D0 (no) 1999-11-12
EP0981524B1 (en) 2003-04-23
CA2289545C (en) 2006-12-12
US6258961B1 (en) 2001-07-10
HU9700884D0 (en) 1997-07-28
EP0981524A1 (en) 2000-03-01
JP4282770B2 (ja) 2009-06-24
PT981524E (pt) 2003-08-29
DE69813792D1 (de) 2003-05-28
ES2195335T3 (es) 2003-12-01
ATE238294T1 (de) 2003-05-15
CA2289545A1 (en) 1998-11-19
HUP9700884A2 (hu) 1999-09-28

Similar Documents

Publication Publication Date Title
BR9809111B1 (pt) intermediários de [2-(2-tienil) etilamino]-(2-clorofenil) acetamida e processo para preparação dos mesmos.
EE200000365A (et) Bispidiini uued arütmiavastased ühendid
PT1021498E (pt) Processo de separacao de compostos aromaticos
PT1256584E (pt) Processo para a preparacao de adefovir-dipivoxil
PT981525E (pt) Novos intermediarios e processo para a sua preparacao
TR199800669A3 (tr) Akrilonitrilin polimerizasyonu için islem
NO20002075D0 (no) Fremgangsmõte ved aminering
DK0987256T3 (da) Krystalform af N-(4-trifluormethylphenyl)-5-methylisoxazol-4-carboxylsyreamid
DE69839679D1 (de) Handlung von verschiedenen protokollen
IT1291551B1 (it) Processo per la preparazione di composti 4-bromometil bifenilici
PT1009436E (pt) Derivado de acridina para aumentar a biodisponibilidade oral do taxol
BR0316400A (pt) agentes branqueadores fluorescentes anfotéricos
BR9914883A (pt) Processo para a racemização
DK0980241T3 (da) Gelatineindkapslede opløsningsdosisformer af sertralin
DK1023292T3 (da) Fremgangsmåde til syntese af chlorpurinintermediater
BR9909756A (pt) Processo para a preparação de um composto
DK0975618T3 (da) Ny fremgangsmåde til fremstilling af 3-N,N-dicyclobutylamino-8-fluor-3,4-dihydro-2H-1-benzopyran-5-carboxamid
BR9809439A (pt) Processos para preparação de benzotiofenos
BR9703825A (pt) Processo para recuperação de amónia não-reagida
PT902020E (pt) Processo aperfeicoado para preparar compostos assimetricos de 4,6-bis(ariloxi)pirimidina
BR0117363B1 (pt) processo para a preparação de um composto 2-cianopiridina de fórmula geral (ii)
ES2192324T3 (es) Procedimiento para preparar una feniltiobutil-isoquinolina y sus intermedios.
IS5544A (is) Nýtt fosfatsalt af ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amíni
BR9702822A (pt) Processo de obtenção de indol-glicosídeos
BR9601575A (pt) Processo para a preparação de um composto heterocíclico e composto

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 28.07.2019